Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

Clinical trial NCT03955445 · RECRUITING

Trial details

NCT number: NCT03955445
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

C3 Glomerulopathy Immune-complex-membranoproliferative Glomerulonephritis

Start date: 2019-10-03
Primary completion: 2036-05-30
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.